Related Experiment Videos
Involvement of complement in atopic dermatitis
Insights
This study found elevated complement components in patients with atopic dermatitis (AD), suggesting the complement system plays a role in AD inflammation. Further research is needed to understand C3a levels in AD.
Area of Science:
- Immunology
- Dermatology
- Complement System
Background:
- Atopic dermatitis (AD) is a common inflammatory skin condition.
- The role of the complement system in AD pathogenesis is not well understood.
- Limited data exists on complement component levels in patients with mild to intermediate AD.
Purpose of the Study:
- To investigate complement component and activation product levels in the peripheral blood of patients with mild to intermediate atopic dermatitis.
- To compare these levels with those in healthy non-atopic individuals.
- To explore potential correlations between complement levels and disease activity.
Main Methods:
- Study included 35 patients with mild to intermediate AD not on systemic or topical steroids for 6 weeks.
- Serum levels of complement components C3, C4, and C1 inhibitor (C1 INA) were measured using radioimmunodiffusion.
- Plasma levels of complement activation products C3a and C5a were quantified via radioimmunoassay.
Main Results:
- Significantly increased levels of C3, C4, and C1 INA were observed in AD patients compared to healthy controls.
- A trend towards elevated C3a levels was noted, though not statistically significant.
- No measurable C5a levels were detected in either group.
- Elevated C3a levels showed a positive correlation with increased C3 levels.
Conclusions:
- The complement system appears to be involved in the inflammatory processes of atopic dermatitis.
- Elevated levels of normal complement components suggest activation or altered regulation in AD.
- Further investigation into the specific role of complement activation products like C3a in AD is warranted.
Abstract:
There is little information about the role of complement in atopic dermatitis (AD). We studied the levels of both normal complement components and activation products in peripheral blood of patients with mild to intermediate disease. 35 patients had not received systemic or topical steroid therapy 6 weeks prior to blood collection. C3, C4 and C1 INA were determined in serum by radioimmunodiffusion. C3a and C5a levels were measured in EDTA plasma by radioimmunoassay. Compared to healthy non-atopic controls C3, C4 and C1 INA were found to be increased significantly. There was a tendency towards increased C3a levels but the difference was not significant. No measurable amounts of C5a were detected. Elevations of C3a were correlated with elevated levels of C3. The results suggest that the complement system participates in the inflammatory process in AD.